Effect of antisense human telomerase RNA on malignant phenotypes of gastric carcinoma

Journal of Gastroenterology and Hepatology (Australia)

Volumn 17, Issue 11, 2002, Pages 1144-1152

  Yang, Shi Ming ^a   Fang, Dian Chun ^a   Yang, Jin Liang ^a   Liang, Guang Ping ^a   Lu, Rong ^a   Lou, Yuan Hui ^a   Liu, Wei Wen ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Antisense gene; Gastric carcinoma; Gene therapy; Human telomerase RNA; Telomerase

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; LIPOSOME; RNA; TELOMERASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EUKARYOTE; FLOW CYTOMETRY; GENE CONSTRUCT; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOLECULAR BIOLOGY; MOLECULAR CLONING; MOUSE; NONHUMAN; NUDE MOUSE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; STOMACH CARCINOMA; TELOMERE;

EID: 0036908463     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2002.02857.x     Document Type: Article

References (32)

1. Morin GB. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesize TTAGGG repeats. Cell 1989; 59: 521-9.
2. Kim NW, Piatyszek MA, Prowse KR et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011-15.
3. Shay JW, Bachetti S. A survey of telomerase activity in human cancer. Eur. J. Cancer 1997; 33: 787-91.
4. Feng J, Funk WD, Wang SS et al. The RNA component of human telomerase. Science 1995; 269: 1236-41.
5. Harrington L, McPhail T, Mar V et al. A mammalian telomerase-associated protein. Science 1997; 275: 973-6.
6. Nakamura TM, Morin GB, Chapman KB et al. Telomerase catalytic subunit homologs from fission yeast and human. Science 1997; 277: 955-9.
7. Weinrich SL, Pruzan R, Ma L et al. Reconstitution of human telomerase with the template RNA component hTR and catalytic protein subunit hTRT. Nat. Genet. 1997; 17: 498-502.
8. Naka K, Yokozaki H, Yasui W et al. Effect of antisense human telomerase RNA transfection on the growth of human gastric cancer cell lines. Biochem. Biophys. Res. Commun. 1999; 255: 753-8.
9. Kondo S, Tanaka Y, Kondo Y et al. Antisense telomerase treatment: Induction of two distinct pathways, apoptosis and differentiation. FASEB J. 1998; 12: 801-11.
10. Rathi A, Hur K, Gazdar AF et al. Telomerase RNA expression during progression of gastric cancer. Hum. Pathol. 1999; 30: 1302-8.
11. Yasui W, Tahara H, Tahara E et al. Expression of telomerase catalytic component, telomerase reverse transcriptase, in human gastric carcinomas. Jpn. J. Cancer Res. 1998; 89: 1099-103.
12. Heine B, Hummel M, Demel G et al. Demonstration of constant upregulation of the telomerase RNA component in human gastric carcinomas usingin situ hybridization. J. Pathol. 1998; 185: 139-44.
13. Hiyama T, Yokozaki H, Kitadai Y et al. In situ mRNA hybridization technique for analysis of human telomerase RNA in gastric precancerous and cancerous lesions. Jpn. J. Cancer Res. 1998; 89: 1187-94.
14. Kuniyasu H, Domen T, Hamamoto T et al. Expression of human teloemrase RNA is an early event of stomach carcinogenesis. Jpn. J. Cancer Res. 1997; 88: 103-7.
15. Yang SM, Fang DC, Luo YH et al. Alterations of telomerase activity and terminal restriction fragment in gastric cancer and its premalignant lesions. J. Gastroenterol. Hepatol. 2001; 16: 876-82.
16. Counter CM, Avillion AA, LeFeure CE et al. Telomerase shortening association with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 1992; 11: 1921-9.
17. Harley CB, Futcher AB, Greider CW. Telomeres shorten during aging of human fibroblasts. Nature 1990; 345: 458-60.
18. Kanazawa Y, Ohkawa K, Ueda K et al. Hammerhead ribozyme-mediated inhibition of telomerase activity in extracts of human hepatocellular carcinoma cells. Biochem. Biophys. Res. Commun. 1996; 225: 570-6.
19. Norton JC, Piatyszek MA, Wright WE et al. Inhibition of human telomerase activity by peptide nucleic acids. Nat. Biotechnol. 1996; 14: 615-19.
20. Mata JE, Joshi SS, Palen B et al. A hexameric phosphorothioate oligonucleotide telomerase inhibitor arrests growth of Burkitt's lymphoma cells in vitro and in vivo. Toxicol. Appl. Pharmacol. 1997; 144: 189-97.
21. Hiyama E, Yokoyama T, Tatsumoto N et al. Telomerase activity in gastric cancer. Cancer Res. 1995; 55: 3258-62.
22. Tahara H, Kuniyasu H, Yokozaki H et al. Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions. Clin. Cancer Res. 1995; 11: 1245-51.
23. Sharma HW, Sokoloski JA, Perez JR et al. Differentiation of immortal cells inhibits telomerase activity. Proc. Natl. Acad. Sci. USA 1995; 92: 12343-6.
24. Savoysky E, Yoshida K, Ohtomo T et al. Down-regulation of telomerase activity is an early event in the differentiation of HL60 cells. Biochem. Biophys. Res. Commun. 1996; 266: 329-34.
25. Albanell J, Han W, Mellado B et al. Telomerase activity is repressed during differentiation of maturation sensitive but not resistant human tumor cell lines. Cancer Res. 1996; 56: 1503-8.
26. Weng NP, Granger L, Hodes RJ. Telomere lengthening and telomerase activation during human B cell differentiation. Proc. Natl. Acad. Sci. USA 1997; 94: 10 827-32.
27. Cheng AJ, Liao SK, Chow SE et al. Differential inhibition of telomerase activity during induction of differentiation in hematopoietic, melanoma, and glioma cells in culture. Biochem. Biophys. Res. Commun. 1997; 237: 438-44.
28. Kim SH, Kaminker P, Campisi J. TIN2, a new regulator of telomere length in human cells. Nat. Genet. 1999; 23: 405-12.
29. Ohyashiki JH, Hayashi S, Yahata N et al. Impaired telomere regulation mechanism by TRF1 (telomere-binding protein), but not TRF2 expression, in acute leukemia cells. Int. J. Oncol. 2001; 18: 593-8.
30. Okabe J, Eguchi A, Masago A et al. TRF1 is a critical trans-acting factor required for de novo telomere formation in human cells. Hum. Mol. Genet. 2000; 9: 2639-50.
31. Smith S, de Lange T. Tankyrase promotes telomere elongation in human cells. Curr. Biol. 2000; 10: 1299-302.
32. Matsutani N, Yokozaki H, Tahara E et al. Expression of telomeric repeat binding factor 1 and 2 and TRF1-interacting nuclear protein 2 in human gastric carcinomas. Int. J. Oncol. 2001; 19: 507-12.